Dayton、OHにおける肺がんの臨床試験
Daytonとその周辺地域（約30マイル以内）の拠点で、肺がんに関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- Miami Valley Hospital, Dayton
- Dayton Physician LLC - Englewood, Dayton
- Miami Valley Hospital North, Dayton
- 他4件
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Dayton Physician LLC - Englewood, Dayton
- Greater Dayton Cancer Center, Kettering · 5マイル先
- Kettering Medical Center, Kettering · 5マイル先
- 他4件
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
被験者募集中第3相
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他3件
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
被験者募集中第3相
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他4件
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
被験者募集中第3相
- Miami Valley Hospital, Dayton
- Miami Valley Hospital North, Dayton
- Miami Valley Hospital South, Centerville · 9マイル先
- 他1件
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
被験者募集中第3相
- Dayton Physician's Network, Dayton
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
被験者募集中第2/3相
- Dayton Physicians Network, Dayton
- Kettering Medical Center, Kettering · 5マイル先
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- Miami Valley Hospital South, Centerville · 9マイル先
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
被験者募集中第3相
- Kettering Medical Center, Kettering · 5マイル先
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
被験者募集中第3相
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他3件
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
被験者募集中
- Dayton VA Medical Center, Dayton
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
被験者募集中第2相
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他4件
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2相
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他3件
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
被験者募集中第2/3相
- Miami Valley Hospital, Dayton
- Premier Blood and Cancer Center, Dayton
- Miami Valley Hospital North, Dayton
- 他3件
他の都市における肺がんの試験
- Houston, TX78件の研究
- Boston, MA62件の研究
- New York City, NY60件の研究
- Los Angeles, CA45件の研究
- Washington, DC41件の研究
- Arlington, VA41件の研究
- Chicago, IL41件の研究
- Nashville, TN40件の研究
- Baltimore, MD40件の研究
- St. Louis, MO39件の研究
- Columbus, OH37件の研究
- Philadelphia, PA36件の研究
Daytonにおける他の研究
- 非小細胞肺癌13件の研究
- 卵巣がん9件の研究
- 脂肪肝8件の研究
- 心不全8件の研究
- 子宮内膜がん7件の研究
- 前立腺がん7件の研究
- がん（全種類）7件の研究
- 悪性黒色腫7件の研究
- 肥満症7件の研究
- 乳がん7件の研究
- 潰瘍性大腸炎6件の研究
- 過体重6件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。